SIGA Technologies
SIGA
#8813
Rank
โ‚ฌ0.21 B
Marketcap
2,93ย โ‚ฌ
Share price
-0.15%
Change (1 day)
-59.13%
Change (1 year)

SIGA Technologies (SIGA) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚ฌ0.39 Million

According to SIGA Technologies's latest financial reports the company's total debt is โ‚ฌ0.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

SIGA Technologies - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚ฌ0.5 M-3.58%
2024-12-31โ‚ฌ0.52 M2.99%
2023-12-31โ‚ฌ0.51 M3.62%
2022-12-31โ‚ฌ0.49 M19.45%
2021-12-31โ‚ฌ0.41 M12.69%
2020-12-31โ‚ฌ0.36 M-99.49%
2019-12-31โ‚ฌ71.82 M8.77%
2018-12-31โ‚ฌ66.03 M11.52%
2017-12-31โ‚ฌ59.21 M-6.41%
2016-12-31โ‚ฌ63.27 M
2014-12-31โ‚ฌ1.63 M-42.92%
2013-12-31โ‚ฌ2.86 M-22.77%
2012-12-31โ‚ฌ3.71 M
2006-12-31โ‚ฌ0.09 M-45.38%
2005-12-31โ‚ฌ0.18 M
2002-12-31โ‚ฌ0.01 M-95.07%
2001-12-31โ‚ฌ0.21 M-83.47%
2000-12-31โ‚ฌ1.31 M65.46%
1999-12-31โ‚ฌ0.79 M-14.18%
1998-12-31โ‚ฌ0.92 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ0.93 B 237,919.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.26 B 67,565.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ4.38 M 1,016.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚ฌ1.33 M 241.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.70 B 180,337.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.51 B 132,308.73%๐Ÿ‡บ๐Ÿ‡ธ USA